Skip to main content

Browse
Archival descriptions
Authority records
Archival institutions
Functions
Subjects
Places
Digital objects

Search

Global search

Advanced search

Clipboard
- Clipboard
- Clear all selections
- Go to clipboard
- Load clipboard
- Save clipboard
Language
- Language
- English
- Français
- Español
- Nederlands
- Português
Quick links
- Quick links
- Help

Have an account?

Email*This field is required.

Password*This field is required.

Research Excellence Framework Archive

Reports

[E] CARRICK THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PHASE 1 CLINICAL TRIAL OF ITS ORAL CDK7 INHIBITOR: CT7001

There are no relevant reports for this item

Cancel

Accessibility Privacy

If you are experiencing technical difficulties using any part of this application please contact Max Communications on 020 8309 5445 or via email at info@maxcommunications.co.uk

Imperial College London endeavours to make its facilities as accessible as possible to everyone. In line with WCAG 2.1 AA requirements, our accessibility statement is available here.

Site development and digitisation carried out by Max Communications Ltd.

For full details of services provided by Max Communications Ltd. Please contact us via our main website or use the details in this footer.

©Copyright - Imperial College London 2024